{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:09:53Z","timestamp":1787731793225,"version":"build-2784847793"},"reference-count":33,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Swedish heart-lung foundation","award":["20180506"],"award-info":[{"award-number":["20180506"]}]},{"name":"Swedish heart-lung foundation","award":["20200645"],"award-info":[{"award-number":["20200645"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2022,11,3]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To describe medical management in aortic dissection (AD) and to analyse the possible associations between antihypertensive, antithrombotic, anticoagulant and statin agents, respectively, and long-term survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>From Swedish medical registers, all patients diagnosed with AD in 2006\u20132015 were identified. Filled prescriptions prior to admission and within 1 year from discharge in patients discharged and alive at 30 days were registered. Associations between pharmacological treatment and long-term survival were analysed using Cox proportional hazards models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 3951 patients hospitalised with acute AD, 3046 (77%) were discharged and alive at 30 days. In hospitalised patients, mean age was 66 years (SD 13), and 36% (n=1098) were women. Within 1 year from discharge, 96% (n=2939) had at least one antihypertensive drug. Beta blocker was the most commonly used drug type (90%, n=2741). Statin treatment (47%, n=1418) was associated with higher long-term survival; HR 0.74 (95% CI 0.63 to 0.87, p&lt;0.001). The positive association between statins and long-term survival remained, in subgroup analysis, in medically managed patients (HR 0.72 (95% CI 0.60 to 0.86, p&lt;0.001)), but not in patients undergoing surgical repair (HR 0.82 (95% CI 0.58 to 1.14, p=0.230)). Beta blockers were associated with favourable long-term survival in surgically managed patients (HR 0.58 (95% CI 0.35 to 0.97, p=0.038)) but not in medically managed patients (HR 0.93 (95% CI 0.72 to 1.12, p=0.057)). Neither antiplatelet therapy nor anticoagulants were associated with long-term survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Statin treatment was associated with favourable long-term outcome in medically managed AD patients, whereas treatment with beta blocker was associated with higher survival only in surgically managed AD patients. Statin use as well as optimal antihypertensive therapy in the chronic stage of the disease need to be further analysed, preferably in randomised controlled trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2022-002082","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T09:25:10Z","timestamp":1668677110000},"page":"e002082","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological treatment in patients with aortic dissection"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-3945","authenticated-orcid":false,"given":"Christian","family":"Smedberg","sequence":"first","affiliation":[{"name":"Department of Clinical Science and Education S\u00f6dersjukhuset, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Surgery, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Hultgren","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-9222","authenticated-orcid":false,"given":"Karin","family":"Leander","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Steuer","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education S\u00f6dersjukhuset, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Surgery, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"2025081611530167000_9.2.e002082.1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5223(19)33192-7","article-title":"Treatment of dissecting aneurysms of the aorta without surgery","volume":"50","author":"Wheat","year":"1965","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081611530167000_9.2.e002082.2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-5223(19)33323-9","article-title":"Surgical management of dissecting aneurysms of the aorta","volume":"49","author":"Debakey","year":"1965","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081611530167000_9.2.e002082.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)65594-4"},{"key":"2025081611530167000_9.2.e002082.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.7.897"},{"key":"2025081611530167000_9.2.e002082.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031264"},{"key":"2025081611530167000_9.2.e002082.6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejvs.2019.08.003","article-title":"Endovascular vs. medical management for uncomplicated acute and sub-acute type B aortic dissection: a meta-analysis","volume":"59","author":"Hossack","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025081611530167000_9.2.e002082.7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejvs.2016.06.005","article-title":"Editor's Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)","volume":"53","author":"Riambau","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025081611530167000_9.2.e002082.8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1540-8191.2006.00213.x","article-title":"Managing emergency hypertension in aortic dissection and aortic aneurysm surgery","volume":"21 Suppl 1","author":"Khoynezhad","year":"2006","journal-title":"J Card Surg"},{"key":"2025081611530167000_9.2.e002082.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.755801"},{"key":"2025081611530167000_9.2.e002082.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2025081611530167000_9.2.e002082.11","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"2025081611530167000_9.2.e002082.12","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001940"},{"key":"2025081611530167000_9.2.e002082.13","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1093\/eurheartj\/ehaa446","article-title":"Sex differences and temporal trends in aortic dissection: a population-based study of incidence, treatment strategies, and outcome in Swedish patients during 15 years","volume":"41","author":"Smedberg","year":"2020","journal-title":"Eur Heart J"},{"key":"2025081611530167000_9.2.e002082.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"2025081611530167000_9.2.e002082.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5288"},{"key":"2025081611530167000_9.2.e002082.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700628"},{"key":"2025081611530167000_9.2.e002082.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01818-5"},{"key":"2025081611530167000_9.2.e002082.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.08.012"},{"key":"2025081611530167000_9.2.e002082.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(01)00662-5"},{"key":"2025081611530167000_9.2.e002082.20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0469","article-title":"Association of long-term use of antihypertensive medications with late outcomes among patients with aortic dissection","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025081611530167000_9.2.e002082.21","article-title":"First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection","volume":"2","author":"Chan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025081611530167000_9.2.e002082.22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"eLife"},{"key":"2025081611530167000_9.2.e002082.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.05.040"},{"key":"2025081611530167000_9.2.e002082.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2017.07.018"},{"key":"2025081611530167000_9.2.e002082.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.11.084"},{"key":"2025081611530167000_9.2.e002082.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"2025081611530167000_9.2.e002082.27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.143131"},{"key":"2025081611530167000_9.2.e002082.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61368-4"},{"key":"2025081611530167000_9.2.e002082.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.09.020"},{"key":"2025081611530167000_9.2.e002082.30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/jamaneurol.2020.2499","article-title":"Trends in antihypertensive medication use among individuals with a history of stroke and hypertension, 2005 to 2016","volume":"77","author":"Santos","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025081611530167000_9.2.e002082.31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jvs.2017.12.063","article-title":"Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate","volume":"68","author":"Martin","year":"2018","journal-title":"J Vasc Surg"},{"key":"2025081611530167000_9.2.e002082.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2019.02.005"},{"key":"2025081611530167000_9.2.e002082.33","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12613"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2022-002082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T18:53:10Z","timestamp":1755370390000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2022-002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/openhrt-2022-002082"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2022-002082","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}